With respect to the MAPK axis, population-level genomics place frequent activation via upstream lesions (e.g., KRAS) across biliary tract cancers, reinforcing the centrality of RAS–RAF–MEK–ERK signaling. This evidence concerns the gene MAP2K7 and biliary tract cancer.